MTHFD2 and cancer: Because of the low expression of MTHFD2 in most adult tissues, targeting MTHFD2 is unlikely to produce significant side effects and MTHFD2 could be as a novel target for cancer therapy (Nishimura et al., 2019; Cuthbertson et al., 2021; Yang et al., 2021).